glioblastoma, Dose Escalation, PRIDE Trial, Bevacizumab, NTCP, FET PET, QA
glioma, health-related quality of life, HRQoL, Hierarchical cluster analysis, HCA, symptom cluster, European Organisation for Research and Treatment of Cancer (EORTC), Dendrogram, Multi-symptom, Gaussian graphical models
PCNSL, primary CNS lymphoma, whole-brain irradiation, WBRT, low-dose WBRT, high-dose WBRT